Treatment of Thrombocytopenia in adults with Hepatitis C
MHRA Drug Safety Update - Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results
Blood and Nutrition
Eltrombopag is recommended as an option for the treatment of thrombocytopenia only in adults with non-genotype 1 HCV infection who have MELD scores <10 and baseline albumin >35g/L.
Reason for decision: